Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's cilostazol 100
mg tablets and Otsuka's Pletal® 100 mg tablets following a single, oral 100 mg(1 x 100 mg)
dose administered under fasting conditions.